The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months
Open accessAbstract
Summary: Purpose: Determine the optimal initial monotherapy for children with newly diagnosed childhood absence epilepsy (CAE) based on 12 months of double‐blind therapy. Methods: A double‐blind, randomized controlled clinical trial compared the efficacy, tolerability, and neuropsychological effects of ethosuximide, valproic acid, and lamotrigine in children with newly diagnosed CAE. Study medications were titrated to clinical response, and subjects remained in the trial unless they reached a treatment failure criterion. Maximal target doses were ethosuximide 60 mg/kg/day or 2,000 mg/day, valproic acid 60 mg/kg/day or 3,000 mg/day, and lamotrigine 12 mg/kg/day or 600 mg/day. Original primary outcome was at 16–20 weeks and included a video–electroencephalography (EEG) assessment. For this report, the main effectiveness outcome was the freedom from failure rate 12 months after randomization and included a video‐EEG assessment; differential drug effects were determined by pairwise comparisons. The main cognitive outcome was the percentage of subjects experiencing attentional dysfunction at the month 12 visit. Key Findings: A total of 453 children were enrolled and randomized; 7 were deemed ineligible and 446 subjects comprised the overall efficacy cohort. There were no demographic differences between the three cohorts. By 12 months after starting therapy, only 37% of all enrolled subjects were free from treatment failure on their first medication. At the month 12 visit, the freedom‐from‐failure rates for ethosuximide and valproic acid were similar (45% and 44%, respectively; odds ratio [OR]with valproic acid vs. ethosuximide 0.94; 95% confidence interval [CI] 0.58–1.52; p = 0.82) and were higher than the rate for lamotrigine (21%; OR with ethosuximide vs. lamotrigine 3.08; 95% CI 1.81–5.33; OR with valproic acid vs. lamotrigine 2.88; 95% CI 1.68–5.02; p < 0.001 for both comparisons). The frequency of treatment failures due to lack of seizure control (p < 0.001) and intolerable adverse events (p < 0.037) was significantly different among the treatment groups. Almost two thirds of the 125 subjects with treatment failure due to lack of seizure control were in the lamotrigine cohort. The largest subgroup (42%) of the 115 subjects discontinuing due to adverse events was in the valproic acid group. The previously reported higher rate of attentional dysfunction seen at 16–20 weeks in the valproic acid group compared with the ethosuximide or lamotrigine groups persisted at 12 months (p < 0.01). Significance: As initial monotherapy, the superior effectiveness of ethosuximide and valproic acid compared to lamotrigine in controlling seizures without intolerable adverse events noted at 16–20 weeks persisted at 12 months. The valproic acid cohort experienced a higher rate of adverse events leading to drug discontinuation as well as significant negative effects on attentional measures that were not seen in the ethosuximide cohort. These 12‐month outcome data coupled with the study’s prespecified decision‐making algorithm indicate that ethosuximide is the optimal initial empirical monotherapy for CAE. This is the first randomized controlled trial meeting International League Against Epilepsy (ILAE) criteria for class I evidence for CAE (or for any type of generalized seizure in adults or children). (NCT00088452.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wechsler Intelligence Scale for Children
(2018) · The SAGE Encyclopedia of Intellectual and Developmental Disorders · doi:10.4135/9781483392271.n537 · Cited by 4,109
Peabody Picture Vocabulary Test
Campbell, J. M., & Dommestrup, A. K. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0649 · Cited by 3,787
Wisconsin Card Sorting Test Manual – Revised and Expanded
Heaton, R. K., Chelune, C., Talley, J., Kay, G., & Curtiss, G. (1981) · Medical Entomology and Zoology · Cited by 2,987
Wisconsin Card Sorting Test manual
Heaton, R. K. (1981) · Medical Entomology and Zoology · Cited by 2,604
Woodcock-Johnson III Tests of Achievement
(2012) · SpringerReference · doi:10.1007/springerreference_180722 · Cited by 1,566
(2017) · The SAGE Encyclopedia of Abnormal and Clinical Psychology · doi:10.4135/9781483365817.n1487 · Cited by 1,252
Wechsler Intelligence Scale for Children
Park, S. E., & Demakis, G. J. (2020) · Encyclopedia of Personality and Individual Differences · doi:10.1007/978-3-319-24612-3_1035 · Cited by 1,079
Woodcock‐Johnson III Tests of Achievement
Dumont, R., & Willis, J. O. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced2229 · Cited by 1,027
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Mattson, R., Perucca, E., & Tomson, T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00585.x · Cited by 790
Self-citationNEPSY : A Developmental Neuropsychological Assessment
Dumont, R., & Willis, J. O. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced1463 · Cited by 769
Test of Nonverbal Intelligence
Brown, L. (2003) · Handbook of Nonverbal Assessment · doi:10.1007/978-1-4615-0153-4_10 · Cited by 673
Developmental Test of Visual-Motor Integration
Beery, K. E., & Buktenica, N. A. (2012) · PsycTESTS Dataset · doi:10.1037/t11054-000 · Cited by 666
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Capparelli, E. V., & Adamson, P. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902014 · Cited by 645
Self-citationCaplan, B. (2018) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-56782-2_3000-2 · Cited by 419
Childhood absence epilepsy: Behavioral, cognitive, and linguistic comorbidities
Caplan, R., Siddarth, P., Stahl, L., Lanphier, E., Vona, P., Gurbani, S., Koh, S., Sankar, R., & Shields, W. D. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01680.x · Cited by 370
Newly Diagnosed Epilepsy in Children: Presentation at Diagnosis
Berg, A. T., Shinnar, S., Levy, S. R., & Testa, F. M. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00739.x · Cited by 272
Self-citationNewly Diagnosed Unprovoked Epileptic Seizures: Presentation at Diagnosis in CAROLE Study
Jallon, P., Loiseau, P., Loiseau, J., & de l'Epilepsie), O. B. O. G. C. (. A. D. R. O. L. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.31400.x · Cited by 254
Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children
Frank, L. M., Enlow, T., Holmes, G. L., Manasco, P., Concannon, S., Chen, C., Womble, G., & Casale, E. J. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00805.x · Cited by 218
Long-term Psychosocial Outcome in Typical Absence Epilepsy: Sometimes a Wolf in Sheeps' Clothing
Wirrell, E. C. (1997) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1997.02170390042008 · Cited by 214
Validation of a New Quality of Life Measure for Children with Epilepsy
Sabaz, M., Cairns, D. R., Lawson, J. A., Nheu, N., Bleasel, A. F., & Bye, A. M. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00240.x · Cited by 213
Wide‐Range Assessment of Memory and Learning
Adams, W. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy1039 · Cited by 207
Absence seizures in children: Clinical and electroencephalographic features
Holmes, G. L., McKeever, M., & Adamson, M. (1987) · Annals of Neurology · doi:10.1002/ana.410210308 · Cited by 204
Loiseau, P., Pestre, M., Datigues, J. F., Commenges, D., Barberger‐Gateau, C., & Cohadon, S. (1983) · Annals of Neurology · doi:10.1002/ana.410130610 · Cited by 198
Holdsworth, L., & Whitmore, K. (1974) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1974.tb03395.x · Cited by 175
Impaired attention and network connectivity in childhood absence epilepsy
Killory, B. D., Bai, X., Negishi, M., Vega, C., Spann, M. N., Vestal, M., Guo, J., Berman, R., Danielson, N., Trejo, J., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.036 · Cited by 171
Effects of sodium valproate in 100 children with special reference to weight.
Egger, J., & Brett, E. M. (1981) · BMJ · doi:10.1136/bmj.283.6291.577 · Cited by 170
Bodyweight Gain and Anticonvulsants: A Comparative Review
Jallon, P., & Picard, F. (2001) · Drug Safety · doi:10.2165/00002018-200124130-00004 · Cited by 159
Berg, A. T., Shinnar, S., Levy, S. R., Testa, F. M., Smith‐Rapaport, S., & Beckerman, B. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb04604.x · Cited by 155
Self-citationBeery-Buktenica Developmental Test of Visual-Motor Integration
Spencer, T. D., & Kruse, L. (2021) · Springer eBooks · doi:10.1007/978-3-319-91280-6_1886 · Cited by 139
Long-term prognosis for childhood and juvenile absence epilepsy
Trinka, E., Baumgartner, S., Unterberger, I., Unterrainer, J. M., Luef, G. J., Haberlandt, E., & Bauer, G. J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0521-1 · Cited by 136
Childhood Absence Epilepsy: Evolution and Prognostic Factors
Grosso, S., Galimberti, D., Vezzosi, P., Farnetani, M., Bartolo, R. M. D., Bazzotti, S., Morgese, G., & Balestri, P. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00277.x · Cited by 134
Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood
Callenbach, P. M. C., Bouma, P. A. D., Geerts, A. T., ARTS, W. F. M., Stroink, H., Peeters, E. A. J., van Donselaar, C. A., Peters, A. C. B., & Brouwer, O. F. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.11.011 · Cited by 92
Petit Mal Epilepsy: Results of a Prolonged Follow-Up Study of 117 Patients
Livingston, S., Torres, I., Pauli, L. L., & Rider, R. V. (1965) · JAMA · doi:10.1001/jama.1965.03090160005001 · Cited by 91
The outcome of absence epilepsy
Bouma, P. A. D., Westendorp, R. G. J., van Dijk, J. G., Peters, A. C. B., & Brouwer, O. F. (1996) · Neurology · doi:10.1212/wnl.47.3.802 · Cited by 82
Differentiation of attention-related problems in childhood absence epilepsy
Vega, C., Vestal, M. L., Desalvo, M. N., Berman, R., Chung, M. H., Blumenfeld, H., & Spann, M. N. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.06.010 · Cited by 69
Wide Range Assessment of Memory and Learning
Serova, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-56782-2_1165-2 · Cited by 68
Wirrell, E. C., Camfield, C., CAMFIELD, P. R., & Dooley, J. M. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.02401.x · Cited by 67
Will a Critical Level of Hyperventilation‐Induced Hypocapnia Always Induce an Absence Seizure?
Wirrell, E. C., CAMFIELD, P. R., Gordon, K., et al. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00592.x · Cited by 67
Reaction time, attention, and impulsivity in epilepsy
Mitchell, W. G., Zhou, Y., Chavez, J. M., et al. (1992) · Pediatric Neurology · doi:10.1016/0887-8994(92)90047-3 · Cited by 64
Currier, R. D., Kooi, K. A., & Saidman, L. J. (1963) · Neurology · doi:10.1212/wnl.13.11.959 · Cited by 63
Data and Safety Monitoring Boards
Friedman, L. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012274065-7/50008-3 · Cited by 48
Longterm Follow-Up of Childhood Epilepsy with Absences - I. Epilepsy with Absences at Onset
Dieterich, E., Baier, W. K., Doose, H., Tuxhorn, I., & Fichsel, H. (1985) · Neuropediatrics · doi:10.1055/s-2008-1052560 · Cited by 41
Loewen, H. J. (2011) · Cited by 37
Clinical and EEG Estimates of Absence Seizure Frequency
Browne, T. R., Dreifuss, F. E., PENRY, J. K., Porter, R. J., & WHITE, B. G. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04210070009004 · Cited by 31
Epstein, M. A., DUCHOWNY, M. S., Jayakar, P. A., Resnick, T., & Álvarez, L. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01790.x · Cited by 29
Pseudoseizures Caused by Hyperventilation Resembling Absence Epilepsy
North, K. N., Ouvrier, R., & Nugent, M. (1990) · Journal of Child Neurology · doi:10.1177/088307389000500403 · Cited by 24
Cited by
Moshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 372
Targeting voltage-gated calcium channels in neurological and psychiatric diseases
Zamponi, G. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.5 · Cited by 368
Adverse drug reactions induced by valproic acid
Nanau, R. M., & Neuman, M. G. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.06.012 · Cited by 321
30 years of second-generation antiseizure medications: impact and future perspectives
Perucca, E., Brodie, M. J., Kwan, P., & Tomson, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30035-1 · Cited by 261
Metadata
- Authors
- Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Adamson, P. C., & for the Childhood Absence Epilepsy Study Team
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2012-11-21
- Volume
- 54
- Issue
- 1
- Pages
- 141-155
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1951203427
- Cited by
- 271
- References
- 48
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.